CARDEAS PHARMA

Cardeas Pharma is developing a novel antibiotic formulation of two drugs with synergistic activity against all relevant, highly resistant Gram-negative bacilli, including Pseudomonas aeruginosa, Acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. In addition, this antibiotic formulation has activity on biofilms. The combination also has activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA). This formulation is administered using ... a single-patient use, vibrating-plate nebulizer that is compatible with all ventilators. The nebulizer creates small, uniform aerosol droplets that deliver drug to the small airways and alveoli. Integration of this novel antibiotic formulation and device has the potential to achieve significant clinical outcomes relative to current standard therapy.

#SimilarOrganizations #People #Financial #Website #More

CARDEAS PHARMA

Industry:

Biotechnology Health Care Medical

Founded:

2010-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.cardeaspharma.com

Total Employee:

11+

Status:

Active

Contact:

206-336-5550

Email Addresses:

[email protected]

Total Funding:

80 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Domain Not Resolving GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads

Similar Organizations

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

impact-biomedicines-logo

Impact Biomedicines

Impact Biomedicines is pioneering the development of life-changing treatments for patients.

praxis-precision-medicines-logo

Praxis Precision Medicines

Praxis Precision Medicines offers drug development services.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Advisors List

thong-le_image

Thong Le Board Observer @ Cardeas Pharma
Board_observer

Founder

bruce-montgomery_image

Bruce Montgomery

Investors List

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Series B - Cardeas Pharma

avalon-ventures_image

Avalon Ventures

Avalon Ventures investment in Series B - Cardeas Pharma

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series B - Cardeas Pharma

h-i-g-biohealth-partners_image

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners investment in Series B - Cardeas Pharma

washington-research-foundation_image

Washington Research Foundation

Washington Research Foundation investment in Series B - Cardeas Pharma

devon-park-bioventures_image

Devon Park BioVentures

Devon Park BioVentures investment in Series B - Cardeas Pharma

devon-park-bioventures_image

Devon Park BioVentures

Devon Park BioVentures investment in Series A - Cardeas Pharma

novo-ventures_image

Novo Ventures

Novo Ventures investment in Series A - Cardeas Pharma

avalon-ventures_image

Avalon Ventures

Avalon Ventures investment in Series A - Cardeas Pharma

Official Site Inspections

http://www.cardeaspharma.com

Host Informations
Whois Informations

Loading ...

More informations about "Cardeas Pharma" on Search Engine